Assembly Biosciences, Inc.

US$20.42As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ASMBHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (19.04%)
Div yield —
ROE (0.03%)
Biotechnology
Beta (5Y) 1.23
PE TTM —
TSR TTM (34.24%)
Mkt cap US$415.8M
ROIC (3.34%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$21
3.32%
(26.57%)
Hold 11|0|2|1|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.26
0.28
0.32
0.33
3.62%
17.63%
23.54%
25.52%
Revenue$M
32.52
33.79
34.63
35.44
5.09%
10.34%
13.89%
14.55%
Peers (US$415.8M)
Cap (US$)
PE
414.7M
2.554x
419.8M
—
Capital
TTM
5Y
10Y
Leveragex
1.294
0.330
0.219
EBIT/Intx
1.084
0.083
0.085
Own earn%
(30.94)
(69.43)
(76.00)
Sh yield%
32.14
63.48
62.08
Owners
Insiders/Inst%
13.76
64.40
Short interest%
4.25
SBC / revenue%
2.66
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
20–29
$1 testx
—
Incr. ROIC%
3